STE Financials

Income Statement
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026
Revenue
1.6B
+6.4%
1.5B
-6.0%
1.6B
+6.2%
1.5B
+2.5%
1.5B
Cost of Revenue
877.7M
+8.6%
808.5M
-9.3%
891.2M
+6.0%
840.7M
+3.2%
814.4M
Gross Profit
710.9M
+3.9%
684.2M
-1.9%
697.2M
+6.4%
655.5M
+1.5%
645.9M
Operating Expenses
415.3M
+4.3%
398.0M
+4.7%
380.3M
-0.5%
382.2M
+0.5%
380.3M
R&D
31.5M
+10.1%
28.6M
-0.7%
28.8M
-2.4%
29.5M
+4.6%
28.2M
SG&A
366.0M
-1.0%
369.7M
+5.1%
351.8M
-0.1%
352.3M
+0.7%
349.7M
Operating Income
295.6M
+3.3%
286.2M
-9.7%
316.9M
+16.0%
273.3M
+2.9%
265.6M
EBITDA
440.3M
+7.4%
410.0M
-6.8%
440.0M
+11.2%
395.7M
+1.6%
389.5M
Net Income
214.1M
+6.5%
201.0M
-8.8%
220.3M
+13.3%
194.5M
+1.0%
192.5M
EPS (Basic)
$2.20
+7.3%
$2.05
-8.9%
$2.25
+14.8%
$1.96
+0.5%
$1.95
EPS (Diluted)
$2.19
+7.4%
$2.04
-8.5%
$2.23
+13.8%
$1.96
+1.0%
$1.94
Shares (Diluted)
97.6M
-0.3%
97.9M
-0.7%
98.6M
+0.0%
98.6M
-0.2%
98.8M
STERIS (STE) — Financials